Search Results - "Chappell, Mike J."

Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma : In vitro and in vivo studies by HUTCHISON, Colin A, COCKWELL, Paul, GOEHL, Hermann, STORR, Markus, BRADWELL, Arthur R, REID, Steven, CHANDLER, Katie, MEAD, Graham P, HARRISON, John, HATTERSLEY, John, EVANS, Neil D, CHAPPELL, Mike J, COOK, Mark

“…Of patients with newly diagnosed multiple myeloma, approximately 10% have dialysis-dependent acute renal failure, with cast nephropathy, caused by monoclonal…”
Get full text

Modelling the dynamics of intramammary E. coli infections in dairy cows: understanding mechanisms that distinguish transient from persistent infections by WHITE, Lisa J, SCHUKKEN, Ynte H, DOGAN, Belgin, GREEN, Laura, DÖPFER, Dörte, CHAPPELL, Mike J, MEDLEY, Graham F

“…The majority of intramammary infections with Escherichia coli in dairy cows result in transient infections with duration of about 10 days or less, although…”
Get full text

Experimental and mathematical analysis of in vitro Pitavastatin hepatic uptake across species by Grandjean, Thomas R. B., Chappell, Mike J., Lench, Alex M., Yates, James W. T., O'Donnell, Charles J.

“…Abstract 1. To investigate the non-linear kinetics of in vitro hepatocyte uptake across species, the OATP substrate Pitavastatin was used as a probe. 2…”
Get full text

Compartmental modelling of the pharmacokinetics of a breast cancer resistance protein by Grandjean, Thomas R.B, Chappell, Mike J, Yates, James T.W, Jones, Kevin, Wood, Gemma, Coleman, Tanya

“…Abstract A mathematical model for the pharmacokinetics of Hoechst 33342 following administration into a culture medium containing a population of transfected…”
Get full text

Compartmental modelling of the pharmacokinetics of a breast cancer resistance protein : 7th IFAC Symposium on Mondeling and Control in Biomedical Systems by GRANDJEAN, Thomas R. B, CHAPPELL, Mike J, YATES, James T. W, JONES, Kevin, WOOD, Gemma, COLEMAN, Tanya

Get full text

Rapid Removal of Free Light Chains from Serum by Hemodialysis for Patients with Myeloma Kidney by Bradwell, Arthur R., Evans, Neil D., Chappell, Mike J., Cockwell, Paul, Reid, Steven D., Harrison, John, Hutchison, Colin, Mead, Graham P.

“…Introduction. Acute renal failure (ARF) develops in 10–15% of patients with multiple myeloma (MM). Typically, complexes of serum free light chains (sFLC) and…”
Get full text